Accelerating cell line development through automation
How to implement automation in cell line development
Mammalian cell line development is an integral part of the biopharmaceutical industry across a diverse array of applications from vaccines, therapeutic protein production, recombinant therapies, and drug screening.
The market growth for biotherapeutics has increased dramatically in the past few decades, especially for monoclonal antibodies, and these slow, manual development cycles can no longer keep pace with industry demand.
In this ebook we focus on:
- The current limitations in cell line development
- The reasons to invest in automation
- Ways to establish and sustain automation within your lab
- The outlook for cell line development